NextGen Healthcare Tops the List in First-Ever KLAS Comprehensive Ambulatory Platforms 2021 Report
Technology Solutions Leader Receives High Marks for Breadth of Portfolio; Interviewed Clients Report Cost Savings and Revenue Gain
The newly published report, which surveyed clients of several leading healthcare technology companies, focuses on ambulatory organizations’ recently accelerated efforts to consolidate their technology solutions to improve integration and reduce vendor complexity. In interviews specifically conducted with “deep adopters” of NextGen Healthcare’s ambulatory IT portfolios, the clients felt NextGen Healthcare’s product portfolio meets “most (if not all)” of the needs of an ambulatory practice, according to the KLAS report.
In addition, the report notes that revenue and staff efficiency improvements are commonly cited by ambulatory organizations as primary reasons they choose to consolidate IT vendors. Notably, all interviewed
“This third-party analyst report reinforces what we’ve known for some time—providers with an integrated platform find tremendous value in driving differentiated experiences and efficiency versus those navigating and maintaining best-of-breed point solutions,” said
The KLAS report concludes that
Click here to learn more about the NextGen® Enterprise integrated solution.
About KLAS
KLAS is a data-driven company on a mission to improve the world’s healthcare by enabling provider and payer voices to be heard and counted. Working with thousands of healthcare professionals, KLAS collects insights on software, services and medical equipment to deliver reports, trending data and statistical overviews. KLAS data is accurate, honest and impartial. The research directly reflects the voice of the healthcare professionals and acts as a catalyst for improving vendor performance. To learn more about KLAS and its insights, visit www.KLASresearch.com.
About
View source version on businesswire.com: https://www.businesswire.com/news/home/20211216006056/en/
Media Contact
(949) 237-6083
tstegmaier@nextgen.com
Investor Relations Contact
(415) 370-9202
mscalo@nextgen.com
Source: